Life Science REIT PLC Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
20M
-200.11%
10M
10M
2M
8M
0M
9M
11M
-22M
0M
-22M
-21.39%
11M
-7M
9M
0M
0M
-20M
-345.32%
9M
-20M
8M
8M
0M
-27M
4M
-27M
0M
-28M
-456.71%
8M
-1M
-27M
0M
-27M
8M
-
0M
8M
0M
0M
0M
8M
0M
8M
0M
8M
-456.71%
0M
0M
8M
0M
8M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
10M
-
5M
6M
1M
0M
0M
4M
9M
-27M
0M
-27M
-456.71%
6M
0M
4M
0M
0M
10M
-
5M
5M
0M
0M
0M
5M
6M
5M
0M
5M
-456.71%
5M
0M
5M
0M
2M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
-456.71%
0M
0M
0M
0M
2M
9M
-
4M
5M
1M
0M
0M
5M
4M
-34M
0M
-35M
-456.71%
5M
0M
5M
0M
2M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
-456.71%
0M
0M
0M
0M
2M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
-456.71%
0M
0M
0M
0M
1M
0M
-
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
-456.71%
0M
0M
0M
0M
1M